Cutaneous T-cell Lymphoma - 27 Studies Found
| Completed |
: Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma : Cutaneous T Cell Lymphoma : 2010-05-25 : Drug: Lenalidomide Lenalidomide Starting Dose Based on Renal Function at Study Entry Baseline Calculated |
| Completed |
: Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) : Cutaneous T Cell Lymphoma : 2014-07-10 : Drug: Micro needle array-Doxorubicin (MNA-D) MNA-D patches will be applied to 3-4 CTCL skin patches or p |
| Completed |
: Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2007-01-22 : Drug: Panobinostat Other Name: LBH589 |
| Terminated |
: Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2009-02-24 : Procedure: skin biopsy Lidocaine 1% c Epinephrine for local anesthesia |
| Withdrawn |
: Trial of Curcumin in Cutaneous T-cell Lymphoma Patients : Cutaneous T-cell Lymphoma : 2009-08-27 :
|
| Completed |
: A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma : Cutaneous T-cell Lymphoma : 2007-02-05 : Drug: APO866 APO866 is administered as 0.126 mg/m²/hr for 4 consecutive days (96 hours), every 3 we |
| Completed |
: Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2007-06-21 : Drug: LBH589 Other Name: panobinostat |
| Completed |
: Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma : Cutaneous T-cell Lymphoma : 2007-11-05 :
|
| Terminated |
: Everolimus in Treating Cutaneous T-cell Lymphoma : Cutaneous T-Cell Lymphoma : 2012-04-02 : Drug: Everolimus The study drug everolimus will be self-ad |
| Completed |
: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma : Persistent or Recurrent Cutaneous T-Cell Lymphoma : 2013-03-28 : Drug: E7777 administered by intravenous (i.v.) infusion over 60 minutes (+/-10 minutes) on 5 consecutive |